Chiral amines are used for defining new drugs and now researchers at the University of St Andrews have developed a synthetic process for the preparation of a class of enantiomerically pure chiral amines. Their efficient and economical method gives rise to entities of a varied structural class, which can be used as building blocks in the synthesis of bioactives.
The researchers claim that this novel technology has diverse applications and may prove to be a substantial benefit to service companies which synthesize novel compound libraries focussing upon compound purity and pharmacological properties.
Scotland's Universities produce world leading research and intellectual property.
Tuesday, 14 February 2012
Optical Micro-rotator for biophotonics...
Working at the particle level sounds tricky to say the least.
“Non-contact” methods (optical tweezing) exist which allow operators to grab and hold particles using light refraction and to move them around at will. This has generated widespread interest and uses in biology and physics but does not allow for rotational control of trapped samples which can be useful in developing biologically and optically driven micromachines.
However at St.Andrews University a new “Optical micro-rotator” system incorporates apparatus for and a method of rotating using a beam of electromagnetic radiation.
Optical micro-manipulation is a growing and important area in the post-genomic era and has an increasingly expanding number of end users. These include biology laboratories in industry, universities and institutes and industrial laboratories studying development of micro-machines, colloids, and bio-engineering. A recent projection for the global marketplace for biophotonics based technologies in 2005 is US$8 billion.
Although it sounds tricky it also sounds like a significant opportunity for those with the technology.
“Non-contact” methods (optical tweezing) exist which allow operators to grab and hold particles using light refraction and to move them around at will. This has generated widespread interest and uses in biology and physics but does not allow for rotational control of trapped samples which can be useful in developing biologically and optically driven micromachines.
However at St.Andrews University a new “Optical micro-rotator” system incorporates apparatus for and a method of rotating using a beam of electromagnetic radiation.
Optical micro-manipulation is a growing and important area in the post-genomic era and has an increasingly expanding number of end users. These include biology laboratories in industry, universities and institutes and industrial laboratories studying development of micro-machines, colloids, and bio-engineering. A recent projection for the global marketplace for biophotonics based technologies in 2005 is US$8 billion.
Although it sounds tricky it also sounds like a significant opportunity for those with the technology.
Investment assessment and a Robust Sharpe ratio...
Financial market turmoil can cause more than just a skipped heart beat for investors but the researchers at The University of St. Andrews are on the case with their Robust Sharpe Ratio.
When markets face south, the Sharpe ratio can lead to better results for assets with lower return and higher risk. This feature is at best dangerous and at worst catastrophic. It also applied to any equivalent return to risk ratio.
The patent pending Robust Sharpe Ratio assesses your own and your clients investment opportunities reliably in any market condition (whereas the Sharpe ratio struggles to do this in mixed and bear markets). The technology can be applied in direct assessments of individual or multiple securities or in computerised investment algorithms.
The original Sharpe Ratio is only fully reliable in bull markets but not in mixed or bear markets. Comparing two assets both expecting a 1% loss during a bear market, the original Sharpe Ratio provides the better assessment for the asset with the higher risk (e.g. a 2% and 0.25% risk would lead to a Sharpe ratio of -0.5 and -4.0, respectively). The Robust Sharpe Ratio solves this problem through the development of a 'synthetic division process' that replaces the Sharpe ratio's conventional division.
Many investment performance measures lead to reasonable rankings of various assets but do not offer sensitive rations, as their assessment scores are of a reasonable order but do not have an intuitive, justifiable meaning underlying the exact scores. The Robust Sharpe Ratio measures performance as return per unit of benchmark equivalent risk, which makes ranking and ratings meaningful
A patent is pending, not only for the Robust Sharpe Ration, but for the robust version of any return/risk ratio providing meaningful ranking and ratings. As return/risk ratios are probably the most common family of investment performace measures, this framework patent has an extensive coverage providing unique opportunities.
When markets face south, the Sharpe ratio can lead to better results for assets with lower return and higher risk. This feature is at best dangerous and at worst catastrophic. It also applied to any equivalent return to risk ratio.
The patent pending Robust Sharpe Ratio assesses your own and your clients investment opportunities reliably in any market condition (whereas the Sharpe ratio struggles to do this in mixed and bear markets). The technology can be applied in direct assessments of individual or multiple securities or in computerised investment algorithms.
The original Sharpe Ratio is only fully reliable in bull markets but not in mixed or bear markets. Comparing two assets both expecting a 1% loss during a bear market, the original Sharpe Ratio provides the better assessment for the asset with the higher risk (e.g. a 2% and 0.25% risk would lead to a Sharpe ratio of -0.5 and -4.0, respectively). The Robust Sharpe Ratio solves this problem through the development of a 'synthetic division process' that replaces the Sharpe ratio's conventional division.
Many investment performance measures lead to reasonable rankings of various assets but do not offer sensitive rations, as their assessment scores are of a reasonable order but do not have an intuitive, justifiable meaning underlying the exact scores. The Robust Sharpe Ratio measures performance as return per unit of benchmark equivalent risk, which makes ranking and ratings meaningful
A patent is pending, not only for the Robust Sharpe Ration, but for the robust version of any return/risk ratio providing meaningful ranking and ratings. As return/risk ratios are probably the most common family of investment performace measures, this framework patent has an extensive coverage providing unique opportunities.
Low Cost Data Encryption...
The University of St.Andrews well known for their work in the area are offering a low cost data encryption method could be used in telecommunications channels where secure encryption of the data is essential i.e. in data channels where 'man-in-th-middle attacks' are prevalent.
Current telecommunications encryption techniques can be computationally expensive as they require either complex software or highly specialised hardware and some form of preliminary security-critical key distribution. Even 'public key' systems require this.
The St. Andrews software technology can be developed to suit any telecommunications application which requires fast but secure encryption of transmission data. Most notably it can be used in mobile device applications, where encryption is required 'onthe fly', e.g. to enhance security in mobile phone and PDA data traffic. It can specifically assist in such applications, targeting against 'eavesdropping' and 'channel-tampering' interference in transmissions.
In an increasingly data centric world that sounds more than useful.
Current telecommunications encryption techniques can be computationally expensive as they require either complex software or highly specialised hardware and some form of preliminary security-critical key distribution. Even 'public key' systems require this.
The St. Andrews software technology can be developed to suit any telecommunications application which requires fast but secure encryption of transmission data. Most notably it can be used in mobile device applications, where encryption is required 'onthe fly', e.g. to enhance security in mobile phone and PDA data traffic. It can specifically assist in such applications, targeting against 'eavesdropping' and 'channel-tampering' interference in transmissions.
In an increasingly data centric world that sounds more than useful.
Anna Synthetic Voice Package...
Text-to-speech technology doesn't stand still and gets better and better with each passing year thanks in large part to the research and development of various universities.
'HTS-Anna' is a voice package for the Festival 2.1 text-to-speech system, using the 2010 HMM-based synthesis system (HTS) engine. The voice package comprises data files containing voice parameters for HMM-based synthesis and a suitable Southern British pronunciation lexicon.
The package is the latest offering from the synthetic speech team at the University of Edinburgh.
'HTS-Anna' is a voice package for the Festival 2.1 text-to-speech system, using the 2010 HMM-based synthesis system (HTS) engine. The voice package comprises data files containing voice parameters for HMM-based synthesis and a suitable Southern British pronunciation lexicon.
The package is the latest offering from the synthetic speech team at the University of Edinburgh.
Assay for anti-viral agents - picornavirus...
Some picornaviruses can cause mild illnesses, such as the common cold whilst others can give rise to serious conditions of the central nervous system, heart, skeletal muscle and liver.This assay allows the evaluation of new drug candidates to inhibit an interaction which is essential for picornaviral replication in a host
Developed by Dr. Martin Ryan of The University of St. Andrews an assay has been created to evaluate the ability of new drug candidates to inhibit an interaction which is essential for picornaviral replication in a host cell. Dr. Ryan's efficient and economic assay may be the key step in the drug discovery and development process, by potentially identifying novel anti-viral agents.
Developed by Dr. Martin Ryan of The University of St. Andrews an assay has been created to evaluate the ability of new drug candidates to inhibit an interaction which is essential for picornaviral replication in a host cell. Dr. Ryan's efficient and economic assay may be the key step in the drug discovery and development process, by potentially identifying novel anti-viral agents.
Optical Fractionation and Sorting...
The University of St. Andrews have introduced techniques for optical microfluidic sorting which will allow biological or other matter to be sorted or fractionated by criteria including size, shape, density and refractive index. The technique may have the ability to sort matter from the scale of macro-molecules all the way up to large cells.
In addition to the technical advantages of optical sorting and fractionation, the inherent simplicity of the approach could allow the system to be integrated with existing laboratory equipment currently found in any research lab or hospital. This method allows a non-invasive technique for the sorting, separation and analysis of biological matter which maintains the "natural" state of the material, in contrast to classical methods of fractionation and sorting including centrifugation, electrophoresis, liquid and solid chromatography and fluorescent and other labelled sorting. These classical techniques often require pre-treatment of biological material or derive an altered product.
In addition to the technical advantages of optical sorting and fractionation, the inherent simplicity of the approach could allow the system to be integrated with existing laboratory equipment currently found in any research lab or hospital. This method allows a non-invasive technique for the sorting, separation and analysis of biological matter which maintains the "natural" state of the material, in contrast to classical methods of fractionation and sorting including centrifugation, electrophoresis, liquid and solid chromatography and fluorescent and other labelled sorting. These classical techniques often require pre-treatment of biological material or derive an altered product.
Medical Imager for Sub-Surface Temperature Mapping...
Looking below a wound dressing is something that many of us would like to do to see how things are progressing. But obviously you can't do that.... or can you?
At St Andrews University an imager operating at millimetre wavelengths allows sub-surface temperature images to be seen from useful depths below the skin surface. The technique simply records the natural emission of the human body and there is no active illumination of the subject, making things extremely safe.
An advance prototype of the imager has already been built and is being evaluated in a control-data trial at Ninewells Hospital, Dundee. The University of St Andrews has applied for UK and PCT patent protection and the research group involved continues to perform R&D in mm-wave technology. Exciting times for looking below the surface safely.
At St Andrews University an imager operating at millimetre wavelengths allows sub-surface temperature images to be seen from useful depths below the skin surface. The technique simply records the natural emission of the human body and there is no active illumination of the subject, making things extremely safe.
An advance prototype of the imager has already been built and is being evaluated in a control-data trial at Ninewells Hospital, Dundee. The University of St Andrews has applied for UK and PCT patent protection and the research group involved continues to perform R&D in mm-wave technology. Exciting times for looking below the surface safely.
Attenuated bi-segmented Bunyavirus vaccine...
You may have heard of Bird Flu but did you know it was a zoonotic disease? Zoonotic diseases are diseases caused by infectious agents that are transmitted between animals and humans. Addressing this area is The University of St. Andrews.
Novel technology researched by the universityprovides attenuated Rift Valley fever viruses (RVFV) for use as vaccines and for the treatment and/or prevention of viral diseases and/or infection. Applied to RVFV the technique results in modified, genetically distinct attenuated RVFV with a bi-segmented genome capable of raising an immune response in animals.
Through reverse genetics the researchers claim that they have developed a modified, attenuated, bi-segmented RVFV which replicates in cell culture and is immunogenic. The technique has broad applications across the Bunyavirus family and provides a platform for developing novel attenuated virus vaccines to a range of viral zoonotic diseases.
Novel technology researched by the universityprovides attenuated Rift Valley fever viruses (RVFV) for use as vaccines and for the treatment and/or prevention of viral diseases and/or infection. Applied to RVFV the technique results in modified, genetically distinct attenuated RVFV with a bi-segmented genome capable of raising an immune response in animals.
Through reverse genetics the researchers claim that they have developed a modified, attenuated, bi-segmented RVFV which replicates in cell culture and is immunogenic. The technique has broad applications across the Bunyavirus family and provides a platform for developing novel attenuated virus vaccines to a range of viral zoonotic diseases.
Subscribe to:
Posts (Atom)